PL320954A1 - Condensed pyridines with a bicyclic, system, method of obtaining and drugs containing them - Google Patents

Condensed pyridines with a bicyclic, system, method of obtaining and drugs containing them

Info

Publication number
PL320954A1
PL320954A1 PL97320954A PL32095497A PL320954A1 PL 320954 A1 PL320954 A1 PL 320954A1 PL 97320954 A PL97320954 A PL 97320954A PL 32095497 A PL32095497 A PL 32095497A PL 320954 A1 PL320954 A1 PL 320954A1
Authority
PL
Poland
Prior art keywords
bicyclic
obtaining
drugs containing
condensed pyridines
pyridines
Prior art date
Application number
PL97320954A
Inventor
Arndt Brandes
Michael Loegers
Gunter Schmidt
Rolf Angerbauer
Carsten Schmeck
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL320954A1 publication Critical patent/PL320954A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL97320954A 1996-07-08 1997-07-04 Condensed pyridines with a bicyclic, system, method of obtaining and drugs containing them PL320954A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19627430A DE19627430A1 (en) 1996-07-08 1996-07-08 Bicyclic condensed pyridines

Publications (1)

Publication Number Publication Date
PL320954A1 true PL320954A1 (en) 1998-01-19

Family

ID=7799218

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97320954A PL320954A1 (en) 1996-07-08 1997-07-04 Condensed pyridines with a bicyclic, system, method of obtaining and drugs containing them

Country Status (30)

Country Link
US (1) US6063788A (en)
EP (1) EP0825185A1 (en)
JP (1) JPH1067751A (en)
KR (1) KR980009247A (en)
CN (1) CN1172803A (en)
AR (1) AR007716A1 (en)
AU (1) AU722365B2 (en)
BG (1) BG61972B1 (en)
BR (1) BR9703886A (en)
CA (1) CA2209609A1 (en)
CO (1) CO4870759A1 (en)
CZ (1) CZ214797A3 (en)
DE (1) DE19627430A1 (en)
EE (1) EE9700151A (en)
HN (1) HN1997000082A (en)
HR (1) HRP970331A2 (en)
HU (1) HUP9701158A1 (en)
ID (1) ID17659A (en)
IL (1) IL121235A0 (en)
MA (1) MA24261A1 (en)
NO (1) NO308738B1 (en)
NZ (1) NZ328260A (en)
PE (1) PE87798A1 (en)
PL (1) PL320954A1 (en)
SG (1) SG46782A1 (en)
SK (1) SK92697A3 (en)
TN (1) TNSN97116A1 (en)
TR (1) TR199700583A2 (en)
YU (1) YU28897A (en)
ZA (1) ZA976021B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
ATE240120T1 (en) 1998-12-23 2003-05-15 Searle Llc COMBINATIONS OF ILEUMGALLIC ACID TRANSPORT INHIBITORS AND FIBRONIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS
DK1140185T3 (en) 1998-12-23 2003-09-29 Searle Llc Combinations of cholesteryl ester transfer inhibitors and bile acid complexing compounds for cardiovascular indications
EP1140190B1 (en) 1998-12-23 2002-11-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
IL143949A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
WO2000038726A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6924313B1 (en) 1999-09-23 2005-08-02 Pfizer Inc. Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6544974B2 (en) 1999-09-23 2003-04-08 G.D. Searle & Co. (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
HK1052183A1 (en) 2000-03-10 2003-09-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
US20050239782A1 (en) * 2001-04-18 2005-10-27 Heintzelman Geoffrey R Arylindenopyridines and related therapeutic and prophylactic methods
US6903109B2 (en) * 2001-04-18 2005-06-07 Ortho-Muniel Pharmaceutical, Inc. Arylindenopyridines and related therapeutic and prophylactic methods
US6958328B2 (en) * 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
CZ20033456A3 (en) 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
ES2333645T3 (en) 2001-06-22 2010-02-25 Bend Research, Inc. PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF MEDICINES AND NEUTRAL POLYMERS.
JP2005518347A (en) 2001-11-02 2005-06-23 ジー．ディー． サール エルエルシー Novel mono- and difluorobenzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
BR0306643A (en) 2002-01-17 2004-10-19 Pharmacia Corp Novel hydroxy alkyl / aryl or keto tiepine compounds as inhibitors of apical bile acid sodium co-dependent transport
JP2005523262A (en) * 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming substances
US20040127510A1 (en) * 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
CL2004001884A1 (en) 2003-08-04 2005-06-03 Pfizer Prod Inc DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS.
ATE540671T1 (en) * 2003-08-04 2012-01-15 Bend Res Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DRUG ADSORBATES AND LIPOPHILIC MICROPHASE-FORMING MATERIALS
WO2005030185A2 (en) 2003-09-26 2005-04-07 Japan Tobacco Inc. Method of inhibiting remnant lipoprotein production
BRPI0414186A (en) 2003-10-08 2006-10-31 Lilly Co Eli compounds, methods of antagonizing cetp activity, treating or preventing a disease, lowering plasma ldl cholesterol in a mammal, treating and / or preventing pathological sequelae, pharmaceutical formulation, and use of a compound
ATE433984T1 (en) 2004-03-26 2009-07-15 Lilly Co Eli COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA
KR20070090248A (en) * 2004-12-18 2007-09-05 바이엘 헬스케어 아게 4-cycloalkyl-substituted tetrahydroquinoline derivatives and their use as pharmaceuticals
EP2548894A1 (en) 2005-02-03 2013-01-23 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
US20080255084A1 (en) 2005-10-21 2008-10-16 Randy Lee Webb Combination of Organic Compounds
DE102006012548A1 (en) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituted chromanol derivatives and their use
PA8801401A1 (en) * 2007-10-25 2009-05-15 Janssen Pharmaceutica Nv ARYLINDENOPIRIMIDINS AND ITS USE AS ADENOSINE A2A
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
NO177005C (en) * 1988-01-20 1995-07-05 Bayer Ag Analogous process for the preparation of substituted pyridines, as well as intermediates for use in the preparation
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
NZ237097A (en) * 1990-02-26 1993-12-23 Squibb & Sons Inc Pyridine derivatives substituted in the 3-position by a phosphinic moiety.
JPH059179A (en) * 1990-09-27 1993-01-19 Takeda Chem Ind Ltd Heterocyclic compound, its production and acat inhibitor

Also Published As

Publication number Publication date
HN1997000082A (en) 1997-12-26
EP0825185A1 (en) 1998-02-25
BG101746A (en) 1998-03-31
SK92697A3 (en) 1998-02-04
EE9700151A (en) 1998-02-16
DE19627430A1 (en) 1998-01-15
AU2844897A (en) 1998-01-15
NO973144D0 (en) 1997-07-07
YU28897A (en) 2000-03-21
KR980009247A (en) 1998-04-30
TNSN97116A1 (en) 2005-03-15
AU722365B2 (en) 2000-08-03
ZA976021B (en) 1998-02-02
AR007716A1 (en) 1999-11-10
IL121235A0 (en) 1998-01-04
US6063788A (en) 2000-05-16
CO4870759A1 (en) 1999-12-27
JPH1067751A (en) 1998-03-10
CZ214797A3 (en) 1998-01-14
HU9701158D0 (en) 1997-09-29
HUP9701158A1 (en) 1999-09-28
ID17659A (en) 1998-01-15
CA2209609A1 (en) 1998-01-08
BR9703886A (en) 1998-11-03
CN1172803A (en) 1998-02-11
BG61972B1 (en) 1998-11-30
NO973144L (en) 1998-01-09
MA24261A1 (en) 1998-04-01
HRP970331A2 (en) 1998-08-31
NO308738B1 (en) 2000-10-23
SG46782A1 (en) 1998-02-20
NZ328260A (en) 1998-09-24
PE87798A1 (en) 1999-02-13
TR199700583A2 (en) 1998-01-21

Similar Documents

Publication Publication Date Title
PL320954A1 (en) Condensed pyridines with a bicyclic, system, method of obtaining and drugs containing them
PL319050A1 (en) 2-aryl-substituted pyridines, method of obtaining and drugs containing them
PL318277A1 (en) Novel substituted axazolydinones, method of obtaining and drugs containing them
PL318278A1 (en) Novel heteroaryl oxazolydinones, method of obtaining and drugs containing them
PL317985A1 (en) Heteroatoms containing cyclopentanopyridynyl oxazolydinones, method of obtaining and drugs containing them
PL317929A1 (en) Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them
PL320953A1 (en) Heterocyclically condensed pyridines, method of obtaining and therapeutic agents containing them
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
GB2280810B (en) Distance detecting method and system
GB9826655D0 (en) System and method for sampling blood
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
GB2316060B (en) Vapor recovery system and method
AU7316487A (en) Fire alarm system, sensor and method
PL314635A1 (en) Derivatives of pyrimidinodione, pyrimidinotrione, triazinodione and tetrahydroquinazolinodione and method of obtaining them
IL142058A (en) Database synchronization and organization system and method
PL316816A1 (en) Derivatives of purin-6-one, method of obtaining them and drugs containing such derivatives
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
PL310038A1 (en) Glycinamide derivatives, methods of obtaining them and drugs containing such derivatives
EP0342513A3 (en) Gas detecting method and system
HUP9802123A3 (en) Baggage pusher device, system and method of use
EP0577402A3 (en) Synchronization signal detector, synchronization signal detecting method and demodulator
GB9300603D0 (en) A method of,and a system for,detecting objects
PL328824A1 (en) Novel triazolopurines, method of obtaining them and their application as drugs
PL310147A1 (en) 2,3-cyclic condensed 1,4-dihydropyridines, method of obtaining them and drugs containing them
AU2667497A (en) Autotransfusion system and method